IMR Press / FBS / Volume 5 / Issue 1 / DOI: 10.2741/S377

Frontiers in Bioscience-Scholar (FBS) is published by IMR Press from Volume 13 Issue 1 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Mitochondrial genetics and osteoarthritis
Show Less
1 Rheumatology Division,Genomic Laboratory INIBIC-Hospital Universitario A Coruna, As Xubias 84, 15006-A Coruna, Spain
2 CIBER-BBN- Instituto de Salud Carlos III-Madrid, Spain
3 Departamento de Medicina, Universidad de Santiago de Compostela, Santiago de Compostela, Spain
Academic Editor:Ali Mobasheri
Front. Biosci. (Schol Ed) 2013, 5(1), 360–368;
Published: 1 January 2013
(This article belongs to the Special Issue Current trends in cartilage and mesenchymal stem cell biology)

The genetic contribution is one of the most notable factors that play a main role in the risk of OA. Despite the genetics of this disease is complex and the finding of risk-related genes has been very challenging, evidence for genetic predisposition has been reported. Besides, in the last years recent evidences indicate that the mitochondrion is implicated in OA. In this context, the mtDNA haplogroups, defined as individual groups characterized by the presence of a particular set of single nucleotide polymorphisms (SNPs) in the mtDNA sequence, emerged as new genetic variants involved in this pathology. Moreover, it has been described that mtDNA damage not only accumulates in OA chondrocytes, but also that OA chondrocytes have limited mtDNA repair capacity. In this review we will focus on the influence of mitochondrial genetics and the mtDNA haplogroups in the prevalence, severity and progression of the OA disease, as well as their incidence on many OA-related features, such as serum levels of OA-related molecular markers, Nitric Oxide production or telomere length.

Back to top